Loading clinical trials...
Loading clinical trials...
The Effect of Amiloride and Spironolactone on Renovascular and Cardiovascular Variables in Patients With Essential Hypertension in a Doubleblinded, Randomized, Placebo-controlled, Crossover Study.
Conditions
Interventions
Spironolactone
Placebo
+1 more
Locations
1
Denmark
Departments of medical research and medicine
Holstebro, Denmark
Start Date
August 1, 2010
Primary Completion Date
August 1, 2015
Completion Date
August 1, 2015
Last Updated
August 20, 2015
NCT06823947
NCT06604897
NCT07448506
NCT07433790
NCT07421388
NCT07421401
Lead Sponsor
Regional Hospital Holstebro
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions